Reporting owner · Q3 2026 · CIK 1106578

Rothblatt Martine A: insider trades.

Rothblatt Martine A reported 741 non-derivative transactions on 64 SEC ownership filings in Q3 2026: 0 open-market purchases and 675 sales ($314.2M), across 1 company.

Transactions
741
Purchases (P)
0
Sales (S)
675
Companies
1
Name as filed
ROTHBLATT MARTINE A

Companies

CompanyRelationshipTransactions
UNITED THERAPEUTICS Corp (UTHR)Director, Officer · Chairperson & CEO741

Transactions

Newest 150 of 741 non-derivative rows. Shares and prices as filed.
DateCompanyCodeSharesPriceOwned afterFiling
2026-09-29UNITED THERAPEUTICS CorpS160$479.59325,263Form 4
2026-09-29UNITED THERAPEUTICS CorpS120$482.28324,643Form 4
2026-09-29UNITED THERAPEUTICS CorpS200$486.77324,443Form 4
2026-09-29UNITED THERAPEUTICS CorpM9,500$117.76333,943Form 4
2026-09-29UNITED THERAPEUTICS CorpS400$472.05333,543Form 4
2026-09-29UNITED THERAPEUTICS CorpS449$472.97333,094Form 4
2026-09-29UNITED THERAPEUTICS CorpS80$473.86333,014Form 4
2026-09-29UNITED THERAPEUTICS CorpS552$475.12332,462Form 4
2026-09-29UNITED THERAPEUTICS CorpS1,395$476.1331,067Form 4
2026-09-29UNITED THERAPEUTICS CorpS2,135$477.09328,932Form 4
2026-09-29UNITED THERAPEUTICS CorpS500$481.22324,763Form 4
2026-09-29UNITED THERAPEUTICS CorpS1,200$479.07325,423Form 4
2026-09-29UNITED THERAPEUTICS CorpS2,309$478.1326,623Form 4
2026-09-28UNITED THERAPEUTICS CorpS200$477.45331,943Form 4
2026-09-28UNITED THERAPEUTICS CorpS601$479.06331,342Form 4
2026-09-28UNITED THERAPEUTICS CorpS1,013$480.18330,329Form 4
2026-09-28UNITED THERAPEUTICS CorpS1,354$481.2328,975Form 4
2026-09-28UNITED THERAPEUTICS CorpS693$482.11328,282Form 4
2026-09-28UNITED THERAPEUTICS CorpS1,539$483.2326,743Form 4
2026-09-28UNITED THERAPEUTICS CorpS825$484.47325,918Form 4
2026-09-28UNITED THERAPEUTICS CorpS1,315$485.45324,603Form 4
2026-09-28UNITED THERAPEUTICS CorpS160$486.01324,443Form 4
2026-09-28UNITED THERAPEUTICS CorpM9,500$117.76333,943Form 4
2026-09-28UNITED THERAPEUTICS CorpS280$472.43333,663Form 4
2026-09-28UNITED THERAPEUTICS CorpS600$473.28333,063Form 4
2026-09-28UNITED THERAPEUTICS CorpS680$474.46332,383Form 4
2026-09-28UNITED THERAPEUTICS CorpS80$475.28332,303Form 4
2026-09-28UNITED THERAPEUTICS CorpS160$476.68332,143Form 4
2026-09-25UNITED THERAPEUTICS CorpS1,648$478.18325,075Form 4
2026-09-25UNITED THERAPEUTICS CorpS200$471.84333,703Form 4
2026-09-25UNITED THERAPEUTICS CorpS800$472.89332,903Form 4
2026-09-25UNITED THERAPEUTICS CorpS543$474.15332,360Form 4
2026-09-25UNITED THERAPEUTICS CorpS1,613$475.28330,747Form 4
2026-09-25UNITED THERAPEUTICS CorpS632$478.95324,443Form 4
2026-09-25UNITED THERAPEUTICS CorpS40$470.56333,903Form 4
2026-09-25UNITED THERAPEUTICS CorpM9,500$117.76333,943Form 4
2026-09-25UNITED THERAPEUTICS CorpS1,280$477.19326,723Form 4
2026-09-25UNITED THERAPEUTICS CorpS2,744$476.13328,003Form 4
2026-09-24UNITED THERAPEUTICS CorpS360$477.58326,563Form 4
2026-09-24UNITED THERAPEUTICS CorpS2,603$470.63330,700Form 4
2026-09-24UNITED THERAPEUTICS CorpS640$469.74333,303Form 4
2026-09-24UNITED THERAPEUTICS CorpM9,500$117.76333,943Form 4
2026-09-24UNITED THERAPEUTICS CorpS580$472.73327,960Form 4
2026-09-24UNITED THERAPEUTICS CorpS437$474.01327,523Form 4
2026-09-24UNITED THERAPEUTICS CorpS320$475.35327,203Form 4
2026-09-24UNITED THERAPEUTICS CorpS280$476.51326,923Form 4
2026-09-24UNITED THERAPEUTICS CorpS2,160$471.77328,540Form 4
2026-09-24UNITED THERAPEUTICS CorpS1,480$478.61325,083Form 4
2026-09-24UNITED THERAPEUTICS CorpS600$479.52324,483Form 4
2026-09-24UNITED THERAPEUTICS CorpS40$480.33324,443Form 4
2026-09-23UNITED THERAPEUTICS CorpS824$491.65327,129Form 4
2026-09-23UNITED THERAPEUTICS CorpS1,440$490.48327,953Form 4
2026-09-23UNITED THERAPEUTICS CorpS2,162$489.52329,393Form 4
2026-09-23UNITED THERAPEUTICS CorpS2,388$488.7331,555Form 4
2026-09-23UNITED THERAPEUTICS CorpM9,500$117.76333,943Form 4
2026-09-23UNITED THERAPEUTICS CorpS270$498.38324,773Form 4
2026-09-23UNITED THERAPEUTICS CorpS766$497.27325,043Form 4
2026-09-23UNITED THERAPEUTICS CorpS525$496.38325,809Form 4
2026-09-23UNITED THERAPEUTICS CorpS155$495.17326,334Form 4
2026-09-23UNITED THERAPEUTICS CorpS160$493.72326,489Form 4
2026-09-23UNITED THERAPEUTICS CorpS240$500.05324,443Form 4
2026-09-23UNITED THERAPEUTICS CorpS480$492.54326,649Form 4
2026-09-23UNITED THERAPEUTICS CorpS90$498.9324,683Form 4
2026-09-22UNITED THERAPEUTICS CorpS160$499.07324,443Form 4
2026-09-22UNITED THERAPEUTICS CorpS1,358$497.73324,603Form 4
2026-09-22UNITED THERAPEUTICS CorpS1,484$496.83325,961Form 4
2026-09-22UNITED THERAPEUTICS CorpS1,488$495.77327,445Form 4
2026-09-22UNITED THERAPEUTICS CorpS1,337$494.66328,933Form 4
2026-09-22UNITED THERAPEUTICS CorpS424$490.54333,279Form 4
2026-09-22UNITED THERAPEUTICS CorpS1,645$493.7330,270Form 4
2026-09-22UNITED THERAPEUTICS CorpS628$492.67331,915Form 4
2026-09-22UNITED THERAPEUTICS CorpS736$491.45332,543Form 4
2026-09-22UNITED THERAPEUTICS CorpM9,500$117.76333,943Form 4
2026-09-22UNITED THERAPEUTICS CorpS240$489.61333,703Form 4
2026-09-21UNITED THERAPEUTICS CorpS1,520$492.97332,423Form 4
2026-09-21UNITED THERAPEUTICS CorpS843$496.62324,443Form 4
2026-09-21UNITED THERAPEUTICS CorpS2,170$494.82327,573Form 4
2026-09-21UNITED THERAPEUTICS CorpS2,287$495.71325,286Form 4
2026-09-21UNITED THERAPEUTICS CorpM9,500$117.76333,943Form 4
2026-09-21UNITED THERAPEUTICS CorpS2,680$493.6329,743Form 4
2026-09-18UNITED THERAPEUTICS CorpM9,500$117.76333,943Form 4
2026-09-18UNITED THERAPEUTICS CorpS248$492.91333,695Form 4
2026-09-18UNITED THERAPEUTICS CorpS2,216$493.78331,479Form 4
2026-09-18UNITED THERAPEUTICS CorpS4,269$494.7327,210Form 4
2026-09-18UNITED THERAPEUTICS CorpS2,330$495.66324,880Form 4
2026-09-18UNITED THERAPEUTICS CorpS160$498.25324,443Form 4
2026-09-18UNITED THERAPEUTICS CorpS277$496.64324,603Form 4
2026-09-17UNITED THERAPEUTICS CorpS332$499.1325,071Form 4
2026-09-17UNITED THERAPEUTICS CorpS468$500.09324,603Form 4
2026-09-17UNITED THERAPEUTICS CorpS160$501.6324,443Form 4
2026-09-17UNITED THERAPEUTICS CorpS151$497.79325,403Form 4
2026-09-17UNITED THERAPEUTICS CorpS1,953$497.17325,554Form 4
2026-09-17UNITED THERAPEUTICS CorpS2,182$496.21327,507Form 4
2026-09-17UNITED THERAPEUTICS CorpS1,905$495.11329,689Form 4
2026-09-17UNITED THERAPEUTICS CorpS1,750$494.34331,594Form 4
2026-09-17UNITED THERAPEUTICS CorpM9,500$117.76333,943Form 4
2026-09-17UNITED THERAPEUTICS CorpS599$493.22333,344Form 4
2026-09-16UNITED THERAPEUTICS CorpS2,080$498.45331,863Form 4
2026-09-16UNITED THERAPEUTICS CorpS1,220$499.15330,643Form 4
2026-09-16UNITED THERAPEUTICS CorpS120$505.2324,443Form 4
2026-09-16UNITED THERAPEUTICS CorpS708$501.52329,443Form 4
2026-09-16UNITED THERAPEUTICS CorpS2,160$502.44327,283Form 4
2026-09-16UNITED THERAPEUTICS CorpS1,538$503.53325,745Form 4
2026-09-16UNITED THERAPEUTICS CorpS1,182$504.17324,563Form 4
2026-09-16UNITED THERAPEUTICS CorpM9,500$117.76333,943Form 4
2026-09-16UNITED THERAPEUTICS CorpS492$500.19330,151Form 4
2026-09-15UNITED THERAPEUTICS CorpS825$502.57325,938Form 4
2026-09-15UNITED THERAPEUTICS CorpS2,689$501.66326,763Form 4
2026-09-15UNITED THERAPEUTICS CorpS780$499.77333,163Form 4
2026-09-15UNITED THERAPEUTICS CorpM9,500$117.76333,943Form 4
2026-09-15UNITED THERAPEUTICS CorpS3,711$500.68329,452Form 4
2026-09-15UNITED THERAPEUTICS CorpS845$503.8325,093Form 4
2026-09-15UNITED THERAPEUTICS CorpS650$504.57324,443Form 4
2026-09-14UNITED THERAPEUTICS CorpS2,722$504.47327,283Form 4
2026-09-14UNITED THERAPEUTICS CorpS2,400$505.25324,883Form 4
2026-09-14UNITED THERAPEUTICS CorpS440$506.48324,443Form 4
2026-09-14UNITED THERAPEUTICS CorpS1,580$502.15332,363Form 4
2026-09-14UNITED THERAPEUTICS CorpM9,500$117.76333,943Form 4
2026-09-14UNITED THERAPEUTICS CorpS2,358$503.44330,005Form 4
2026-09-11UNITED THERAPEUTICS CorpS850$503.1326,353Form 4
2026-09-11UNITED THERAPEUTICS CorpS710$503.99325,643Form 4
2026-09-11UNITED THERAPEUTICS CorpS1,560$502.13327,203Form 4
2026-09-11UNITED THERAPEUTICS CorpS476$500.86328,763Form 4
2026-09-11UNITED THERAPEUTICS CorpS204$499.61329,239Form 4
2026-09-11UNITED THERAPEUTICS CorpS1,021$498.97329,443Form 4
2026-09-11UNITED THERAPEUTICS CorpS82$504.97325,561Form 4
2026-09-11UNITED THERAPEUTICS CorpS518$506.44325,043Form 4
2026-09-11UNITED THERAPEUTICS CorpS320$507.31324,723Form 4
2026-09-11UNITED THERAPEUTICS CorpS280$508.21324,443Form 4
2026-09-11UNITED THERAPEUTICS CorpM9,500$117.76333,943Form 4
2026-09-11UNITED THERAPEUTICS CorpS1,341$496.74332,602Form 4
2026-09-11UNITED THERAPEUTICS CorpS2,138$497.99330,464Form 4
2026-09-10UNITED THERAPEUTICS CorpS1,536$502.8326,883Form 4
2026-09-10UNITED THERAPEUTICS CorpS578$503.76326,305Form 4
2026-09-10UNITED THERAPEUTICS CorpS702$505.03325,603Form 4
2026-09-10UNITED THERAPEUTICS CorpS600$505.94325,003Form 4
2026-09-10UNITED THERAPEUTICS CorpS280$506.76324,723Form 4
2026-09-10UNITED THERAPEUTICS CorpS280$508.8324,443Form 4
2026-09-10UNITED THERAPEUTICS CorpM9,500$117.76333,943Form 4
2026-09-10UNITED THERAPEUTICS CorpS120$498.44333,823Form 4
2026-09-10UNITED THERAPEUTICS CorpS1,788$499.75332,035Form 4
2026-09-10UNITED THERAPEUTICS CorpS1,372$500.58330,663Form 4
2026-09-10UNITED THERAPEUTICS CorpS2,244$501.88328,419Form 4
2026-09-09UNITED THERAPEUTICS CorpS160$497.56331,223Form 4
2026-09-09UNITED THERAPEUTICS CorpS400$498.85330,823Form 4
2026-09-09UNITED THERAPEUTICS CorpS519$499.73330,304Form 4
2026-09-09UNITED THERAPEUTICS CorpS361$500.84329,943Form 4
2026-09-09UNITED THERAPEUTICS CorpS1,017$502.87328,926Form 4
2026-09-09UNITED THERAPEUTICS CorpS1,144$503.6327,782Form 4
2026-09-09UNITED THERAPEUTICS CorpS964$505.03326,818Form 4

Questions

What stock did Rothblatt Martine A buy or sell?

Rothblatt Martine A reported 741 non-derivative transactions on 64 SEC ownership filings in Q3 2026: 0 open-market purchases and 675 sales ($314.2M), across 1 company.

Is Rothblatt Martine A the same person as other filers with this name?

This page covers SEC CIK 1106578 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.

Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.

Plain-text version for agents and LLMs: /insiders/rothblatt-martine-a-1106578.md

Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.